Long noncoding RNA (lncRNA) is >200 nucleotides long and lacks coding ability. LncRNA was regarded as transcript noise, until emerging results showed its roles in development, homeostasis and carcinogenesis. LncRNAs containing microRNA (miRNA) response elements could compete with the miRNA target gene and regulate its expression through decreasing free functional miRNA. Such lncRNA is called competing endogenous RNA (ceRNA), and the 'lncRNA-miRNA' interaction appreciably enriches the world of RNA-RNA regulation. Gastric cancer involves dysregulation of both protein-coding genes and noncoding genes, and the ceRNA regulatory mechanism may participate in this pathogenic process. In this review, we discuss recent findings on the roles of ceRNAs in gastric carcinogenesis.
Introduction
The human transcriptome is composed of only 2% of proteincoding RNA and 98% of noncoding RNA; however, the latter was considered as dark matter and did not draw the researchers' attention until recent years [1] [2] [3] [4] [5] . Long noncoding RNAs (lncRNAs) are functional RNAs deprived of coding potential; however, increasing evidence brings up the idea that lncRNAs could be an important class of permeative genes contributing to tumorigenesis [6] . Recent studies have reported diverse RNA species could form an intricate network, such as protein-coding messenger RNAs (mRNAs) and lncRNAs. These RNA transcripts could communicate with each other and pose reciprocal regulation by acting as competing endogenous RNAs (ceRNAs); in other words, these RNAs could compete to bind to common microRNAs (miRNAs), a cluster of small noncoding RNAs that are involved with posttranscriptional regulation of gene expression [7] [8] [9] [10] [11] [12] . This mutual competition for miRNA leads to a decrease in free miRNA concentration, and thus an impairment of miRNA activity [13] [14] [15] . It is widely accepted that a single miRNA could regulate multiple target mRNAs through complementary binding to the 3 0 untranslated region (3 0 -UTR) [16] . Conversely, a given mRNA could bear target sites for a considerable number of miRNAs, which could form a novel 'RNA-miRNA-RNA' interplay [17] . Understanding this complex RNA crosstalk in gene regulatory networks will provide significant insight into human development and diseases. Research on lncRNAs has witnessed a spectacular increase in these years. To date, long noncoding ceRNAs have been shown to function in several types of cancer including thyroid cancer, liver cancer, gallbladder cancer, etc [15, 18, 19] . Gastric cancer (GC) is one of the most prevalent cancer types worldwide. As the majority of patients have poor outcomes, it is crucial to understand the molecular mechanisms for GC and develop more effective therapeutic strategies. Here, we give an overview of the roles of lncRNAs as ceRNAs in GC.
patterns in GC vary substantially across geographical regions [22, 23] , reflecting an uneven distribution of the key factors for GC incidence and mortality across different countries. The incidence and mortality of GC have decreased, mainly because of the reduction in the prevalence of Helicobacter pylori infection and smoking, and to the improvements in food preservation for the past years. However, GC remains a high burden for public health, especially in Asia, Latin America and Central and Eastern European areas [24, 25] . Our world witnesses great improvements in medical technologies and treatment strategies; however, major obstacles to the treatment of GC persist, including delayed diagnosis, recurrence and metastasis [26, 27] . Therefore, it is important to further clarify the molecular mechanisms of GC and to identify biomarkers for the diagnosis and prognosis of GC. Carcinogenesis in the stomach is complex and includes multiple steps, involving numerous genetic and epigenetic alterations [28] . Studies over the past decades mostly focused on the protein-coding genes. The discovery of new functions in the noncoding RNAs (ncRNAs) is inducing a paradigm alteration in our understanding of gene regulation and its role in cancer development. LncRNAs are defined as ncRNAs with >200 nucleotides in length, and have emerged as a major class of regulatory factors that participate in a broad range of biological and pathological processes. LncRNAs have been subsequently reported to be involved in gene dysregulation in different types of cancers. The significance of lncRNAs in human GC was reported in 2012, when Feng and colleagues found the role of H19 in GC [29] . The H19 gene, which belongs to a highly conserved imprinted gene cluster [30, 31] , was dramatically upregulated in GC cell lines and GC tissues. H19 was also found to promote GC cell proliferation [29] . Following this research, a series of studies focused on the aberrant expression of lncRNAs during GC have been reported. Accumulating results indicated that specific lncRNAs had potential pathological and clinical relevance in GC [32] [33] [34] [35] [36] [37] [38] [39] .
Competing endogenous RNA
The mysterious roles of lncRNAs used to be regarded as the dark matter of the genome which are gradually coming to light with our knowledge of the transcriptome space expanding. LncRNAs have been implicated in various ways of gene regulation, such as chromatin dosage compensation, epigenetic regulation, mRNA splicing and translation [40] [41] [42] ; thus, dysregulation of these key regulators would inevitably lead to diseases. It has become increasingly evident that a wide range of RNA transcripts bearing a number of miRNA-binding sites, contributing to the hypothesis that all RNA transcripts that contain miRNA-binding sites could connect with and influence each other by competing specifically for common miRNAs, can thus act as ceRNAs [17, 43, 44] (schematic representation in Figure 1 ). The previous mode, 'miRNAs-RNAs' regulation, now has been evolved to 'RNAs-miRNAs-RNAs' interaction [17] .
The ceRNA network has three main characteristics. The first one is that the relative concentration of the ceRNAs and corresponding miRNAs could appreciably impact the effectiveness of the interaction. Altered expression of the ceRNAs in different conditions should reach a certain level, to cause or relieve the miRNA suppression on ceRNAs. Second, the range of miRNAs that a ceRNA may interact largely depends on the subcellular localization and tissue/cell specificity of ceRNA [45] . As the expression of miRNA is dependent on time, cell/tissue type, developmental stage and pathological context, the availability of ceRNA under these conditions would also affect its overall influence [46] . Third, the miRNA response elements (MREs) on ceRNAs are not equal. For example, two different MREs are predicted to bind the same miRNA; the partial difference in nucleotide composition of MREs could lead to distinct affinity of each MRE to bind a miRNA and is critical for overall ceRNA function [17] .
A multitude of lncRNAs have displayed cell type-, tissue type-, developmental stage-and disease-specific expression Roles of competing endogenous RNAs in gastric cancer | 267 modes [15, 18, 19, 47] , suggesting that individual lncRNA could be a potent natural miRNA decoy in certain conditions. Two such examples of long noncoding ceRNAs that have emerged, highlighting the significance of these miRNA-lncRNA competitive crosstalk, are CCAT1 and PTCSC3. The lncRNA CCAT1 was first reported as a significantly upregulated transcript in colorectal cancer (CRC), with 2628 bp length that maps to chromosome 8q24.21 [48] . Moreover, abnormal upregulation of CCAT1 promotes cell proliferation and migration in GC cells [32] . More recently, CCAT1 was demonstrated to be highly expressed in gallbladder carcinoma tissues. CCAT1 promoted the miRNA-218-5p target gene Bmi1 by competitively binding to miRNA-218-5p, and CCAT1 could significantly stimulate the proliferation and invasiveness of GBC cells. In contrast to CCAT1 that is upregulated in cancerous tissues, PTCSC3 was found to be dramatically downregulated in thyroid cancers [19] . PTCSC3 expression is highly thyroid specific. Overexpression of PTCSC3 in thyroid cancer cells inhibits cell growth and stimulates cell cycle arrest and apoptosis, suggesting that PTCSC3 plays a crucial role in thyroid carcinogenesis. Further investigation revealed PTCSC3 could bind miR-574-5p, which was reported to accelerate proliferation of several human cancer cells and exert influence on CRC tumorigenesis, and it could serve as a biomarker for chemoresistance and poor survival in patients with small-cell lung cancer [49] [50] [51] . These two studies indicate that the disease-specific alteration of specific lncRNAs and associated ceRNA crosstalk may effect on the carcinogenic process.
ceRNA in GC
Theoretically, any RNA transcript that bears MREs is capable of sequestering miRNAs and constructing intricate ceRNA-miRNA networks that when perturbed may contribute to cancer [8, 52] . Growing evidence suggests that lncRNAs could also have roles as ceRNAs, connecting miRNAs and the posttranscriptional crosstalk in gastric pathogenesis. Explicating this novel RNA interplay will provide new insight into the underlying mechanisms of tumorigenesis and pave the way for developing new therapeutic methods against GC.
Long noncoding ceRNA-HOTAIR
HOTAIR is as a spliced and polyadenylated lncRNA containing 2158 nucleotides [53] . HOTAIR is transcribed from the antisense strand of HoxC gene, and it is a trans-acting lncRNA with different target loci [53, 54] . HOTAIR initially became well known for its oncogenic functions in primary and metastatic breast cancer [55] . Furthermore, HOTAIR expression level positively correlates with malignant behavior and poor prognosis in diverse cancers such as hepatocellular carcinoma and pancreatic cancer [56] [57] [58] [59] [60] [61] . Recent studies showed that HOTAIR was upregulated in GC [62, 63] . Additionally, its experimental upregulation promoted GC cells proliferation, migration and invasion, whereas its inhibition dramatically turned back the promotion. Hyperactivity of HOTAIR was correlated with bigger tumor dimensions, higher disease stage, prolonged metastasis status and shorter survival of GC patients.
Mechanistic analysis reveals that nuclear HOTAIR can target polycomb repressive complex 2, altering H3K27 methylation and gene expression patterns across the genome [55, 56] . More interestingly, HOTAIR could also function as a ceRNA to compete for miR-331-3p in gastric pathogenesis [64] (Figure 2 ). Bioinformatics analysis of miRNA recognition sequences on HOTAIR revealed the presence of 11 tumor-suppressive miRNAs-binding sites. MiRNAs are known to be present in the cytoplasm in the form of miRNA ribonucleoprotein complexes that also contain Ago2, the core component of the RNA-induced silencing complex [65, 66] . HOTAIR: miR-331-3P coimmunoprecipitation with anti-Ago2 demonstrated a physical interaction in GC cells, providing further support for HOTAIR's miRNAsequestering activity.
In carcinomas, human epithelial growth factor receptor 2 (HER2) encodes a 185 kDa transmembrane protein that triggers multiple signaling pathways involved in cell proliferation, apoptosis, motility and angiogenesis [67] [68] [69] [70] . HER2 was predicted to be one of miR-211-3p target genes, with luciferase assay to prove this interaction. Bivariate correlation analysis showed that expression of HER2 was significantly correlated with HOTAIR transcript level in GC tissues compared with normal counterparts. This indicates that HOTAIR acts as ceRNA by binding miR-311-3p, thus abolishing the miRNA-induced suppressing activity on the HER2 3 0 -UTR.
Thus, the identification of long noncoding ceRNAs will undoubtedly enhance our knowledge of how lncRNAs function, allowing us to better understand the pathogenesis and development of GC and finally facilitate the development of lncRNAbased diagnostics and therapeutics against this deadly disease. It is reasonable for us to anticipate that there may be many other lncRNAs that function as ceRNAs to regulate expression of key genes in GC.
Long noncoding ceRNA-GAPLINC
Our previous study found that GAPLINC, a long intergenic noncoding RNA (lincRNA) sitting on the shorter arm of chromosome 18 (924 bp long), is highly expressed in GC tissues with cancerpredictive value. Experimental validation based on patients with different clinicopathologic features suggested that GAPLINC high expression was a strong indicator of poor prognosis, and it was correlated with larger average tumor size, more frequent of severe lymph node invasion and shorter patient survival [71] .
GAPLINC repression could significantly inhibit the proliferation and invasion of GC cell lines MGC803 and SGC7901, whereas knocking down of GAPLINC facilitates apoptosis and cycle arrest in both cell lines. GAPLINC might be a facilitating factor in the gastric carcinogenesis and development, with gene expression profiling in GC cells revealing alterations in cell migration pathways and with CD44 expression as the most highly correlated after downregulation of GAPLINC. CD44 is a wellcharacterized factor that contributes to a broad range of tumor occurrence and progression, including GC [72] [73] [74] [75] [76] . Overexpression of GAPLINC increased CD44 mRNA level in GC cells, and the effects of GAPLINC on cell migration and proliferation were suppressed by interfering CD44 mRNA [71] . Through the high-throughput ArrayStar assay, we are the first group to uncover that GAPLINC is not only a strong indicator, but also a main factor contributing to GC occurrence and progression. Therefore, probing into the mechanism of this novel lincRNA regulating its downstream gene CD44 might provide us with more information of lncRNA taking part in GC.
Interestingly, a miRNA, namely miR211-3p, was predicted to target both CD44 and GAPLINC, with remarkable binding energy estimated by the widely used RNAup algorithm [77] (Figure 2 ). Further mechanistic investigations validated the ceRNA hypothesis that GAPLINC regulates CD44 as a molecular sponge for miR211-3p. The examples of GAPLINC and HOTAIR representing as ceRNAs give us a hint that a wide variety of lncRNA might exert its regulation through acting as ceRNA in GC.
Long noncoding ceRNA-tumor suppressor candidate 7
Another long noncoding ceRNA example is tumor suppressor candidate 7 (TUSC7), which was first discovered by Qi and colleagues in 2015 [78] (Figure 2 ). The author first performed an lncRNA microarray in eight GC and paired paracancerous tissues, and used gene coexpression network to identify potential lncRNA. TUSC7 was found out to be linked to a number of lncRNAs and mRNAs; thus, it was chosen to study on. Sequential analysis demonstrated that low expression of TUSC7 was associated with more aggressive behavior and poorer prognosis in GC patients, such as a worse pathologic grade, a deeper and nervous invasion. The Kaplan-Meier method with the logrank test showed that decreased TUSC7 expression was an independent risk factor of disease-free survival and diseasespecific survival in GC patients. Additionally, TUSC7 was underexpressed in GC samples compared with corresponding normal gastric tissues, indicating a protective role of TUSC7. Further functional study revealed that TUSC7 suppressed tumor cell growth both in vitro and in vivo. The p53 tumor suppressor was predicted and experimentally validated to be the upstream transcription factor via interaction with the putative p53-response element in the upstream region of TUSC7. Ultimately, through a series of processes, including miRNA prediction, RNA expression detection and RNA immunoprecipitation, miR-26b was indicated to bind to TUSC7. It should be noted that miR-23b could not only significantly promote cell growth and but rescue the effects of TUSC7 overexpression. It has been demonstrated that TUSC7 and miR-23b were expressed in negative correlation in clinical specimens, and could pose reciprocal repression. Altogether, TUSC7 is a p53-regulated tumor suppressor that acts partially by decreasing miR-23b, and TUSC7 may be a key regulatory factor in GC. However, the other side of the ceRNAtarget genes of miR-23b was not proposed in this study.
Identification of long noncoding ceRNAmiRNA interaction
Another study aimed to develop a new approach to construct ceRNA network and to make it easier to search for cancer-associated long noncoding ceRNAs [79] (flowchart shown in Figure 3 ). The study focused on GC-associated lncRNAs; thus, 17 lncRNAs differentially expressed between GC tissues and paracancerous tissues were selected on the lncRNAs expression profiles combined with Encyclopedia of DNA Elements [80] . Applying the previously reported GC-associated miRNAs [81] , the author tried to discover these miRNA-associated long noncoding ceRNAs. Because miRNAs are interacting with lncRNAs through their MREs within ceRNA network, it is a matter of great urgency to search for the potential MREs in lncRNAs. The ceRNA hypothesis relies on knowledge of the precise number and location of MREs. This study applied miRcode [82] to identify miRNA targets, and it showed that 13 miRNAs may interact with 9 of 17 lncRNAs; thus, a ceRNA network in silico was constructed. To establish lncRNA-miRNA-mRNA network (ceRNA network), the next step was to search for miRNAs' mRNA targets. Based on those miRNAs that might interact with lncRNAs, the researchers explored miRNAs' mRNA targets with experimental support tool using TarBase [83] . The results showed that nine miRNAs and eight lncRNAs may be included in the RNA-RNA regulated complex. To confirm this network, a regression analysis based on the gene expression data of several other types of cancer, including head and neck squamous cell carcinoma, prostate cancer, papillary thyroid carcinoma, etc. Finally, several experimental data were also included to prove the ceRNA network. This work revealed that FER1L4 ceRNA interacted with RB1 mediated by miR-106a-5p, and pointed out that H19 might interact with MYCN ceRNA mediated by miR-19a-3p, Roles of competing endogenous RNAs in gastric cancer | 269 and LINC00152 ceRNA might interact with THBS1 mediated by miR-18a-5p. Although several ceRNA interactions were predicted without experimental validation, this new approach of predicting cancer associated-ceRNA network may provide useful information for discovering interactive RNAs that may functionally compete with each other.
Several dedicated tools have been developed to facilitate the identification of ceRNA networks, including Cupid [84] , Hermes [85] , starBase [86] , cefinder [87] , inCeDB [88] and Linc2GO [89] . The features of these tools and resources have been summarized in Table 1 . With the advances of bioinformatic tools, the identification of cancer-related ceRNA networks would be more efficient and accurate.
Conclusion
The ceRNA hypothesis was first brought up in the year 2011 and was rapidly considered as a hallmark in the general understanding the world of RNA-RNA regulation. CeRNA-based gene regulation is an arising area of investigation that would remarkably rise our comprehension of cancer molecular mechanism.
The molecular mechanisms of GC have been better understood in the past two decades [90] ; however, a large number of GC are diagnosed in advanced stages, leading to the loss of the opportunity for radical surgery and poor prognosis and unsatisfactory survival [91] . Generally, multiple genes and signaling pathways are disrupted in GC [92] . Upregulation of ceRNAs raises the abundance of specific MREs and shifts the miRNA pool distribution, as a result, leading to the increased expression of target mRNA. Given the crucial roles of transcriptome alterations in carcinogenesis and the pervasiveness of ceRNA interplay, it is sensible for us to anticipate an increasing number of ceRNA networks being identified in GC. The effectiveness of ceRNA crosstalk may be influenced by several factors such as the relative level of miRNA abundance and ceRNA abundance, and subcellular localization of the individual molecule.
HOTAIR is a widely known lncRNA to play vital role in the etiology of various types of cancer, and recent researches revealed this well-known factor could act as ceRNA to exert its influence on target genes. GAPLINC and TUSC7 are newly reported lncRNAs, and could also take on the ceRNA role in GC occurrence and development. Since the ceRNA hypothesis was proposed, several tools have been developed to help the discovery of ceRNA network in cancer. As a summary, the novel connection between alternative gene expression and long noncoding ceRNA network further highlights the advantages of understanding tumorigenesis from a systematic perspective. The study on the roles of long noncoding ceRNA in GC is still in its early stage, and future explorations may provide more mechanistic insights and potential biomarkers for GC.
Key Points
• LncRNAs containing miRNA-binding sites could act as ceRNAs and play a vital role in gastric carcinogenesis and progression.
• CeRNAs could communicate with each other and pose reciprocal regulation through competing to bind to common miRNAs, which forms a novel 'RNA-miRNA-RNA' interplay.
• So far, only a few of lncRNAs, such as HOTAIR, GAPLINC and TUSC7 are reported as ceRNAs in GC, but more ceRNAs are waiting to be explored.
• A number of bioinformatics tools are developed to help us discover the ceRNA interaction, for example, miRcode could be used to search for miRNA binding to lncRNA, and TarBase could be used to find miRNA target genes.
